Back to results
US 2018/0002447 A1Published application
Plasma kallikrein binding proteins
AssigneeDyax Corp.
InventorsDaniel J. Sexton, Malini Viswanathan
Life of this patent
Estimating the term…
Abstract
Plasma kallikrein binding proteins and methods of using such proteins are described.
Claims21
-24. (canceled)
An isolated monoclonal antibody, which binds human plasma kallikrein (pKal), wherein the monoclonal antibody binds at or near the active site of the catalytic domain of the pKal, or binds an epitope that overlaps with the active site of the catalytic domain of the pKal.
Dependencies are inferred from the claim text.